Benign Prostatic Hyperplasia

Study: Non-Bothering Nocturia Worth Treating

Study: Non-Bothering Nocturia Worth Treating

By

Over 12 weeks of treatment, the mean number of nocturia episodes decreased by 1.1 and 0.9 in men who were and were not bothered by their symptoms, a non-significant difference between groups.

Metabolic Syndrome, Smoking Up Nocturia Risk in BPH

Metabolic Syndrome, Smoking Up Nocturia Risk in BPH

By

Men with metabolic syndrome or a smoking history had more than triple the risks for persistent moderate to severe nocturia after TURP.

Nocturia More Bothersome Than Daytime LUTS

Nocturia More Bothersome Than Daytime LUTS

By

Clinicians tend to focus on the number of voids, but patients worry more about interrupted sleep.

Prostatic Urethral Lift Effective for Obstructive Middle Lobes

Prostatic Urethral Lift Effective for Obstructive Middle Lobes

By

The procedure improves symptoms at least as well in men with obstructive middle lobes as those with obstructive lateral lobes.

Metabolic Syndrome May Increase BPH Risk

Metabolic Syndrome May Increase BPH Risk

By

Men older than 50 with metabolic syndrome had significantly greater risks for BPH than men without the syndrome.

AUA Issues New Surgical Treatment Guidelines for LUTS

AUA Issues New Surgical Treatment Guidelines for LUTS

By

New clinical guidelines for the surgical management of lower urinary tract symptoms attributable to enlarged prostate offer 22 recommendations.

Certain Anticholinergic Drugs Appear to Raise Dementia Risk

Certain Anticholinergic Drugs Appear to Raise Dementia Risk

Dementia link seen with antidepressant, urological, and anti-Parkinson's drugs.

5α-Reductase Inhibitors Not Tied to High-Grade Prostate Cancer

5α-Reductase Inhibitors Not Tied to High-Grade Prostate Cancer

A previous study showed that using 5-ARIs to treat benign prostate hyperplasia decreased the risk of low-grade PCa.

BPH Risk May Be Lower Among Allopurinol Users

BPH Risk May Be Lower Among Allopurinol Users

By

Men using allopurinol had a 22% lower risk of a BPH diagnosis.

Sexual Adverse Effects of BPH Drug Treatment Clarified

Sexual Adverse Effects of BPH Drug Treatment Clarified

By

Decrease in scores on the Men's Sexual Health Questionnaire mostly due to ejaculation disorders.

Water Ablation for BPH Lessens Risk of Ejaculatory Dysfunction

Water Ablation for BPH Lessens Risk of Ejaculatory Dysfunction

By

A novel approach called "Aquablation" provides results comparable to TURP, but with a decreased likelihood of retrograde ejaculation.

Prostatic Urethral Lift Benefits Durable Out to 5 Years

Prostatic Urethral Lift Benefits Durable Out to 5 Years

By

Patients who underwent the minimally invasive procedure had a 36%, 50%, and 44% improvement in IPSS, quality of life, and peak flow rate, respectively, at 5 years.

Dutasteride Linked to Adverse Sexual Side Effects

Dutasteride Linked to Adverse Sexual Side Effects

By

Long-term use of the drug may predispose men to worsening erectile dysfunction and elevated risk of diabetes and non-alcoholic fatty liver disease.

'Real-World' Data Support PUL Use for LUTS

'Real-World' Data Support PUL Use for LUTS

By

PUL involves placement of small permanent metallic implants into the prostate that lift the lateral lobes away from the urethra and remove obstruction.

BPH Risk Linked to Use of Prescription NSAIDs

BPH Risk Linked to Use of Prescription NSAIDs

By

NSAID users had a 2-fold increased risk of BPH medication use, 59% increased risk of a recorded BPH diagnosis, and 61% increased risk for BPH surgery.

Prostate Photovaporization for BPH Beneficial Long-Term

Prostate Photovaporization for BPH Beneficial Long-Term

By

Average International Prostate Symptom Score remained low 5 years after the PVP laser procedure.

New-Onset Urinary Incontinence Common After HoLEP for BPH

New-Onset Urinary Incontinence Common After HoLEP for BPH

By

Researchers identified a predictor of new-onset UI after HoLEP that may aid urologists in clinical practice.

Water Vapor Ablation Eases BPH-Related Urinary Retention

Water Vapor Ablation Eases BPH-Related Urinary Retention

By

In a study, 81.1% of men were able to void after an average of 28 days after treatment.

Prostatic Urethral Lift an Effective Option for Obstructed Patients

Prostatic Urethral Lift an Effective Option for Obstructed Patients

By

In a study, 86% of prostatic urethral lift patients experienced symptom relief in the first month.

5ARIs Raise Risk of Self-Harm, Depression

5ARIs Raise Risk of Self-Harm, Depression

By

Study confirms small, but significant increases in the risks of these mental health problems among men taking the medication.

Use of 5-ARIs May Reduce Blood Loss During TURP

Use of 5-ARIs May Reduce Blood Loss During TURP

By

The finasteride and dutasteride recipients had significantly less mean blood loss than the placebo group.

Prostatic Enlargement Linked to Obesity

Prostatic Enlargement Linked to Obesity

By

Benign prostatic hyperplasia is more likely to develop among men with larger waist circumference and body mass index and higher leptin levels.

Preop Foley Catheter Associated With TURP, TULIP Failure

Preop Foley Catheter Associated With TURP, TULIP Failure

Poor baseline functional status and having a Foley catheter preoperatively were associated with greater risk of TURP or TULIP failure.

Study: 5-ARIs Do Not Increase PCa Death Risk

Study: 5-ARIs Do Not Increase PCa Death Risk

By

New findings confirm previous reports.

PAE Is a Promising BPH Treatment Alternative

PAE Is a Promising BPH Treatment Alternative

The procedure may be particularly efficacious for men with very large prostates.

Sexual Problems Linked to 5ARI Use for BPH

Sexual Problems Linked to 5ARI Use for BPH

By

Use of 5ARIs for BPH was associated with a statistically significant increased, pooled relative risk for sexual dysfunction.

Prostate, Bladder Cancer Linked to BPH

Prostate, Bladder Cancer Linked to BPH

By

In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.

HoLEP Improvements in BPH Symptoms Durable Out to 10 Years

HoLEP Improvements in BPH Symptoms Durable Out to 10 Years

By

Patients experienced a sustained decrease in AUA Symptom Score, and 95% of patients report being satisfied or very satisfied with the procedure.

Sign Up for Free e-newsletters